Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tolerance induction for islet transplantation

B G Exner1, K Fowler, S T Ildstad

  • 1Institute for Cellular Therapeutics, Allegheny University of the Health Sciences, Philadelphia, PA, USA. exner@ahus.edu

Annals of Transplantation
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advanced resuscitative interventions in refractory out-of-hospital cardiac arrest: a retrospective cohort study of a physician-led pre-hospital team.

Resuscitation plus·2026
Same author

Skin and respiratory ill-health attributed to occupational face mask use.

Occupational medicine (Oxford, England)·2022
Same author

Characterization of Human CD8(+)TCR(-) Facilitating Cells In Vitro and In Vivo in a NOD/SCID/IL2rγ(null) Mouse Model.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Measurement of the charge asymmetry in top quark pair production in <i>pp</i> collisions at [Formula: see text] using the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same author

Search for lepton flavour violation in the <i>eμ</i> continuum with the ATLAS detector in [Formula: see text]<i>pp</i> collisions at the LHC.

The European physical journal. C, Particles and fields·2015
Same author

Measurement of [Formula: see text] production with a veto on additional central jet activity in <i>pp</i> collisions at [Formula: see text] TeV using the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same journal

Comparison of Health-Related Quality of Life After Pure Laparoscopic vs Open Donor Hepatectomy in a Low-Volume Living Donor Liver Transplantation Center: A Retrospective Cohort Study.

Annals of transplantation·2026
Same journal

Development and Validation of an Early Post-Liver Transplant Activity Knowledge, Attitude, and Practice Questionnaire for Intensive Care Unit Nurses: A Multicenter Study.

Annals of transplantation·2026
Same journal

Opioid-Sparing Effects of Peripheral Nerve Blocks in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.

Annals of transplantation·2026
Same journal

Brain Death-Induced Systolic Ventricular Dysfunction and Its Association With NLRP3-Related Inflammatory Signaling in a Murine Model.

Annals of transplantation·2026
Same journal

Development and Internal Validation of a Web-Based Dynamic Nomogram for Dynamic Risk Stratification of Early Bacterial Infection in Liver Transplant Recipients.

Annals of transplantation·2026
Same journal

A New Lifeline: Feasibility and Outcomes of Altruistic Donor Programs in Living-Donor Liver Transplantation, A Single Saudi Center Experience.

Annals of transplantation·2026
See all related articles

Hematopoietic chimerism shows promise for treating Type I diabetes by inducing graft tolerance and preventing autoimmune recurrence. Safer methods are explored to avoid complications associated with traditional bone marrow transplantation (BMT).

Area of Science:

  • Immunology
  • Endocrinology
  • Transplantation Science

Background:

  • Type I diabetes is a systemic autoimmune disease impacting glucose homeostasis.
  • Pancreatic graft transplantation faces challenges from rejection and autoimmune recurrence.
  • Hematopoietic chimerism via bone marrow transplantation (BMT) is a novel therapeutic strategy.

Purpose of the Study:

  • To explore hematopoietic chimerism as a strategy for Type I diabetes treatment.
  • To induce tolerance to pancreatic islet grafts and prevent autoimmune destruction.
  • To identify safer methods for achieving hematopoietic chimerism without severe complications.

Main Methods:

  • Review of strategies for inducing hematopoietic chimerism.
  • Analysis of risks associated with conventional BMT (GVHD, engraftment failure, conditioning).

Related Experiment Videos

  • Exploration of alternative approaches to BMT for Type I diabetes.

    • Main Results:

    • Hematopoietic chimerism offers potential for tolerance induction and prevention of autoimmune recurrence in Type I diabetes.
    • Conventional BMT carries significant risks (GVHD, engraftment failure) making it unsuitable for non-malignant diseases like Type I diabetes.
    • Safer strategies for achieving hematopoietic chimerism are under investigation.

    Conclusions:

    • Hematopoietic chimerism holds significant therapeutic potential for Type I diabetes management.
    • Developing safer BMT alternatives is crucial for clinical application in Type I diabetes.
    • This approach could enable tolerance to islet allografts and early autoimmune intervention.